Company Filing History:
Years Active: 2012-2013
Title: Sarah Silverman: Innovator in Nitric Oxide Synthase Inhibition
Introduction
Sarah Silverman is a prominent inventor based in Toronto, Canada. She has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that inhibit nitric oxide synthase (NOS). With a total of 3 patents to her name, her work has the potential to impact various medical conditions.
Latest Patents
Her latest patents include innovative compounds such as benzoxazines and benzothiazines, which are designed to selectively inhibit neuronal nitric oxide synthase (nNOS). These compounds can be utilized in treating or preventing a range of medical conditions. Another notable patent features quinolones and tetrahydroquinolines, which also target nNOS, showcasing her focus on developing effective NOS inhibitors.
Career Highlights
Sarah Silverman is associated with Neuraxon, Inc., where she continues to advance her research in nitric oxide synthase inhibition. Her work is characterized by a commitment to improving therapeutic options for patients suffering from various ailments.
Collaborations
Some of her notable coworkers include Jailall Ramnauth and Subhash Annedi, who contribute to her innovative projects and research endeavors.
Conclusion
Sarah Silverman is a trailblazer in the field of nitric oxide synthase inhibition, with a promising portfolio of patents that could lead to significant advancements in medical treatments. Her contributions reflect her dedication to innovation and improving healthcare outcomes.